AN2 Therapeutics, Inc.
ANTX
$-0.07
Change (1 day)
$22.22
Year High
$0.87
Year Low
Categories
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Dividend history for AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. made a total of 11 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $7.14
Dividend payments for AN2 Therapeutics, Inc. (ANTX) from 2015 to 2018
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| January 11, 18 | $0.66 | $0.66 |
| October 12, 17 | $0.66 | $0.66 |
| July 12, 17 | $0.66 | $0.66 |
| April 11, 17 | $0.66 | $0.66 |
| January 11, 17 | $0.66 | $0.66 |
| October 12, 16 | $0.66 | $0.66 |
| July 13, 16 | $0.66 | $0.66 |
| April 13, 16 | $0.66 | $0.66 |
| January 13, 16 | $0.66 | $0.66 |
| October 13, 15 | $0.66 | $0.66 |
| July 13, 15 | $0.58 | $0.58 |